Home
Product Overview
Company Background
Senior Management
Board of Directors
Scientific Advisors
Collaborations
Contact Us
Brilacidin
Stages of Development
Stock Information
Financials & Filings
Corporate Governance
Investor FAQ
Welcome
Press Releases
Updates
Events and Presentations
Expanded Access
Email Alerts
Stock Symbol: IPIX
Latest News
GET EMAIL ALERTS
Stock Symbol: IPIX
Latest News
GET EMAIL ALERTS

Innovation Pharmaceuticals Inc.

Home
Product Overview
Company Background
Senior Management
Board of Directors
Scientific Advisors
Collaborations
Contact Us
Brilacidin
Stages of Development
Stock Information
Financials & Filings
Corporate Governance
Investor FAQ
Welcome
Press Releases
Updates
Events and Presentations
Expanded Access
Email Alerts
Daniel Pizza
October 25, 2016

9. 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID2015) Oral Mucositis Poster

Daniel Pizza
October 25, 2016
Newer Post5. Joint 55th Interscience Conference on Antimicrobial Agents & Chemotherapy and 28thInternational Congress of Chemotherapy (ICAAC)
Older Post14a-c Brilacidin PK-PD Data Presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2013 Posters
Back to Top
Contact Us
Email alerts

Follow Us

Legal

Forward-Looking Statements
Terms of Use
Privacy Policy
Social Media Disclosure

COPYRIGHT © INNOVATION 2021

Leo-Ehrlich-6.png

Innovation Pharmaceuticals (IPIX) is a publicly traded clinical stage biopharmaceutical company developing innovative therapies to address areas of unmet need. The Company also is active in evaluating other potential investment opportunities that can add value and diversify its portfolio.

Click here for a Corporate Overview.